ALK	anaplastic lymphoma kinase
ASPS	alveolar soft part sarcoma
AYA	adolescent and young adult
CART	chimeric antigen receptor T cell
CDK	cyclin-dependent kinase
CML	chronic myeloid leukemia
FGFR	fibroblast growth factor receptor
GIST	gastrointestinal stromal tumor
HDAC	histone deacetylases
HER2	human epidermal growth factor 2
HLA	human leukocyte antigen
IC50	half maximal inhibitory concentration
IDO1	indoleamine 2,3-dioxygenase 1
IGF-1R	insulin-like growth factor 1 receptor
IMT	inflammatory myofibroblastic tumor
mTOR	mammalian target of rapamycin
ORR	objective response rate
OS	overall survival
PD-1	programmed death-1
PDGFR	platelet-derived growth factor receptor
PEComa	perivascular epithelioid cell tumor
PFS	progression-free survival
PI3K	phosphatidylinositol 3-kinase
RANKL	receptor activator of nuclear factor κB ligand
STS	soft tissue sarcoma
TKI	tyrosine kinase inhibitor
TRK	tropomysin receptor kinase
UPS	undifferentiated pleomorphic sarcoma
VEGFR	vascular endothelial growth factor receptor